Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9224728 | 0.91 | TRPV4 (0.33) | TRPV4ALDH1A1 | |
| SCHEMBL25778066 | 0.88 | TRPV4 (0.35) | TRPV4ALDH1A1ADORA2AADORA1PTPN1 | |
| SCHEMBL25778158 | 0.85 | TRPV4 (0.33) | TRPV4ALDH1A1MAPK1RECQL | |
| SCHEMBL5154882 | 0.85 | TRPV4 (0.33) | TRPV4 | |
| SCHEMBL9849624 | 0.82 | TRPV4 (0.37) | TRPV4 | |
| SCHEMBL9225315 | 0.80 | TRPV4 (0.31) | TRPV4ALDH1A1 | |
| SCHEMBL8080367 | 0.79 | TRPV4 (0.41) | TRPV4ALDH1A1MAPK1MEN1TP53 | |
| SCHEMBL9154264 | 0.79 | TRPV4 (0.39) | TRPV4MAPK1RECQL | |
| SCHEMBL9688285 | 0.79 | TRPV4 (0.39) | TRPV4 | |
| SCHEMBL5155293 | 0.77 | TRPV4 (0.37) | TRPV4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230131274-A1 | P-TYPE ORGANIC SEMICONDUCTOR MATERIAL, MANUFACTURING METHOD OF SAME, AND DISPLAY PANEL | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2023-04-27 | — | — | US | disclosed |
| WO-2021237820-A1 | P-TYPE ORGANIC SEMICONDUCTOR MATERIAL, PREPARATION METHOD AND DISPLAY PANEL | 武汉华星光电半导体显示技术有限公司 | 2021-12-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230131274-A1 | P-TYPE ORGANIC SEMICONDUCTOR MATERIAL, MANUFACTURING METHOD OF SAME, AND DISPLAY PANEL | SELP, ATP5PO, PTPRO | TRPV4 707/4885ALDH1A1 2097/4885ADORA2A 1602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.